journal article·2024-01

Versatile phototheranostic system: Aza-BODIPY-based nanoparticles with B,O-chelated core and diiodine

Leping Chen, Yanfen Wang, Tingyu Shi, Tiantian Ma, Yang Li, Huayu Qiu, Shouchun Yin, Meier Gu

Dyes and Pigments· Volume 221
Publisher page

Abstract

No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.

Source: Not provided · Quality: missing

Research context

OpenAlex topics: Nanoplatforms for cancer theranostics · Luminescence and Fluorescent Materials · Photodynamic Therapy Research Studies

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (56)

Show source-provided references
1. Chemotherapy: a double-edged sword in cancer treatment10.1007/s00262-021-03013-3 ↗
2. Nanomaterials for theranostics: recent advances and future challenges10.1021/cr300213b ↗
3. NIR-II organic nanotheranostics for precision oncotherapy10.1002/smll.202102646 ↗
4. Advanced fluorescence imaging technology in the near-infrared-II window for biomedical applications10.1021/jacs.0c07022 ↗
5. In vivo dissolution of poorly water-soluble drugs: proof of concept based on fluorescence bioimaging10.1016/j.apsb.2020.08.002 ↗
6. Recent advances in contrast-enhanced photoacoustic imaging: overcoming the physical and practical challenges10.1021/acs.chemrev.2c00627 ↗
7. Recent advances of smart AIRgens for photoacoustic imaging and phototherapy10.1016/j.ccr.2022.214725 ↗
8. Recent progress in near-infrared photoacoustic imaging10.1016/j.bios.2021.113478 ↗
9. Activatable molecular agents for cancer theranostics10.1039/C9SC05460J ↗
10. Recent developments in multimodality fluorescence imaging probes10.1016/j.apsb.2018.03.010 ↗
11. Near infrared (NIR) absorbing dyes as promising photosensitizer for photo dynamic therapy10.1016/j.ccr.2020.213233 ↗
12. Photothermal-based nanomaterials and photothermal-sensing: an overview10.1016/j.bios.2022.114883 ↗
13. Photodynamic-based combinatorial cancer therapy strategies: tuning the properties of nanoplatform according to oncotherapy needs10.1016/j.ccr.2022.214495 ↗
14. BODIPY-based photothermal agents with excellent phototoxic indices for cancer treatment10.1021/jacs.2c11650 ↗
15. Solutions to the drawbacks of photothermal and photodynamic cancer therapy10.1002/advs.202002504 ↗
16. Aza-BODIPY probe-decorated mesoporous black tio2 nanoplatform for the highly efficient synergistic phototherapy10.1021/acsami.0c10531 ↗
17. 2-pyridone-functionalized aza-BODIPY photosensitizer for imaging-guided sustainable phototherapy10.1016/j.biomaterials.2018.08.034 ↗
18. Mitochondria-targeting phototheranostics by aggregation-induced NIR-II emission luminogens: modulating intramolecular motion by electron acceptor engineering for multi-modal synergistic therapy10.1002/adfm.202110526 ↗
19. NIR-II phototherapy agents with aggregation-induced emission characteristics for tumor imaging and therapy10.1016/j.biomaterials.2022.121535 ↗
20. Bioapplications of small molecule aza-BODIPY: from rational structural design to in vivo investigations10.1039/D0CS00234H ↗
21. Basic structural modifications for improving the practical properties of BODIPY10.1016/j.ccr.2022.214684 ↗
22. Aza-BODIPY-based nanomedicines in cancer phototheranostics10.1021/acsami.0c05021 ↗
23. Boosting O2•− photogeneration via promoting intersystem-crossing and electron-donating efficiency of aza-BODIPY-based nanoplatforms for hypoxic-tumor photodynamic therapy10.1002/smtd.202000013 ↗
24. A bright, renal-clearable NIR-II brush macromolecular probe with long blood circulation time for kidney disease bioimaging10.1002/anie.202114273 ↗
25. Aza-BODIPY encapsulated polymeric nanoparticles as an effective nanodelivery system for photodynamic cancer treatment10.1039/D0QM00891E ↗
26. Recent strategies to develop innovative photosensitizers for enhanced photodynamic therapy10.1021/acs.chemrev.1c00381 ↗
27. Recent advances in photonanomedicines for enhanced cancer photodynamic therapy10.1016/j.pmatsci.2020.100685 ↗
28. Reexamining the heavy-atom-effect: the universal heavy-atom-induced fluorescence enhancement principle for through-space conjugated AIEgens10.1016/j.cej.2022.139030 ↗
29. Breaking classic heavy-atom effect to achieve heavy-atom-induced dramatic emission enhancement of silole-based AIEgens with through-bond and through-space conjugation10.1002/adom.202101228 ↗
30. BODIPY derivatives for photodynamic therapy: influence of configuration versus heavy atom effect10.1021/acsami.7b07569 ↗
31. Phototherapy and optical waveguides for the treatment of infection10.1016/j.addr.2021.114036 ↗
32. An all-round athlete on the track of phototheranostics: subtly regulating the balance between radiative and nonradiative decays for multimodal imaging-guided synergistic therapy10.1002/adma.202003210 ↗
33. Precise molecular engineering of small organic phototheranostic agents toward multimodal imaging-guided synergistic therapy10.1021/acsnano.1c00585 ↗
34. Rigidity bridging flexibility to harmonize three excited-state deactivation pathways for NIR-II-fluorescent-imaging-guided phototherapy10.1002/adhm.202101003 ↗
35. Regulating the photophysical property of organic/polymer optical agents for promoted cancer phototheranostics10.1002/adma.201806331 ↗
36. Conformationally restricted and ring-fused aza-BODIPYs as promising near infrared absorbing and emitting dyes10.1016/j.ccr.2022.214709 ↗
37. Near-infrared absorbing (>700 nm) aza-BODIPYs by freezing the rotation of the aryl groups10.1016/j.cclet.2021.06.083 ↗
38. Molecular engineering of near-infrared light-responsive BODIPY-based nanoparticles with enhanced photothermal and photoacoustic efficiencies for cancer theranostics10.7150/thno.34418 ↗
39. A facile, protein-derived supramolecular theranostic strategy for multimodal-imaging-guided photodynamic and photothermal immunotherapy in vivo10.1002/adma.202109111 ↗
40. Nitric oxide imaging in cancer enabled by steric relaxation of a photoacoustic probe platform10.1039/C9SC05600A ↗
41. Near-infrared small molecule coupled with rigidness and flexibility for high-performance multimodal imaging-guided photodynamic and photothermal synergistic therapy10.1039/D0NH00672F ↗
42. Donor/π-bridge manipulation for constructing a stable NIR-II aggregation-induced emission luminogen with balanced phototheranostic performance10.1002/anie.202111767 ↗
43. Engineering of BODIPY-based theranostics for cancer therapy10.1016/j.ccr.2022.214908 ↗
44. Photosensitizers for photodynamic therapy10.1002/adhm.201900132 ↗
45. AIE bioconjugates for biomedical applications10.1002/adom.202000162 ↗
46. All-in-one theranostic platforms: deep-red AIE nanocrystals to target dual-organelles for efficient photodynamic therapy10.1021/acsnano.2c04465 ↗
47. Type I photosensitizers revitalizing photodynamic oncotherapy10.1002/smll.202006742 ↗
48. Precise molecular engineering of type i photosensitizers with near-infrared aggregation-induced emission for image-guided photodynamic killing of multidrug-resistant bacteria10.1002/advs.202104079 ↗
49. Dual-step irradiation strategy to sequentially destroy singlet oxygen-responsive polymeric micelles and boost photodynamic cancer therapy10.1016/j.biomaterials.2021.120959 ↗
50. Covalent organic framework nanocarriers of singlet oxygen for oxygen-independent concurrent photothermal/photodynamic therapy to ablate hypoxic tumors10.1002/smll.202202369 ↗
51. Tailored engineering of novel xanthonium polymethine dyes for synergetic PDT and PTT triggered by 1064 nm laser toward deep-seated tumors10.1002/smll.202100398 ↗
52. Acceptor planarization and donor rotation: a facile strategy for realizing synergistic cancer phototherapy via type I PDT and PTT10.1021/acsnano.1c10019 ↗
53. Exploiting the dynamics of the EPR effect and strategies to improve the therapeutic effects of nanomedicines by using EPR effect enhancers10.1016/j.addr.2020.06.005 ↗
54. Cationization to boost both type I and type II ros generation for photodynamic therapy10.1016/j.biomaterials.2021.121255 ↗
55. Indocyanine green assembled free oxygen-nanobubbles towards enhanced near-infrared induced photodynamic therapy10.1007/s12274-022-4085-0 ↗
56. Aza-BODIPY-based phototheranostic nanoagent for tissue oxygen auto-adaptive photodynamic/photothermal complementary therapy10.1007/s12274-021-3552-3 ↗